LET’S GET TO A KEY SOURCE WITH NUCALA

NUCALA is a targeted biologic treatment, approved for 5 conditions. Click on yours below to see how NUCALA might help.

Autoinjector for patients 12+.

Approved Use

NUCALA is approved for the following:

  • Chronic Obstructive Pulmonary Disease (COPD)—NUCALA is an add-on, prescription maintenance treatment of eosinophilic COPD in adults whose disease is not controlled. NUCALA is not used to treat sudden breathing problems.
  • Severe Eosinophilic Asthma (SEA)—NUCALA is an add-on, prescription maintenance treatment for patients 6 and older with SEA. NUCALA is not used to treat sudden breathing problems.
  • Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)—NUCALA is a prescription medicine for add-on maintenance treatment of CRSwNP in adults whose disease is not controlled with nasal corticosteroids.
  • Eosinophilic Granulomatosis with Polyangiitis (EGPA)—NUCALA is a prescription medicine for the treatment of adults with EGPA.
  • Hypereosinophilic Syndrome (HES)—NUCALA is a prescription medicine for the treatment of people 12 years of age and older with HES for 6 months or more.
Get to it

Looking for support? We’ve got your back.

MyNUCALA offers many resources, like:

  • Answers to your questions about NUCALA
  • Guidance and tools to help you work with your specialty pharmacy
  • Refill text reminders

Talk to your doctor to see if adding NUCALA is right for you.

Approved Uses & Safety Info

Approved Uses

Important Safety Information

Approved Uses

NUCALA is a prescription medicine for the:

  • add-on maintenance treatment of patients 6 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
  • add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults whose disease is not controlled with nasal corticosteroids.
  • add-on maintenance treatment of eosinophilic chronic obstructive pulmonary disease (COPD) in adults whose disease is not controlled. NUCALA is not used to treat sudden breathing problems.
  • treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA).
  • treatment of people 12 years of age and older with hypereosinophilic syndrome (HES) for 6 months or more.

Important Safety Information

Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.

Do not use to treat sudden breathing problems.

NUCALA can cause serious side effects, including:

  • allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen after you get your NUCALA injection. Allergic reactions can sometimes happen hours or days after you get a dose of NUCALA. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • swelling of your face, mouth, and tongue
    • breathing problems
    • fainting, dizziness, feeling lightheaded (low blood pressure)
    • rash
    • hives
  • herpes zoster infections that can cause shingles have happened in people who received NUCALA.

Before receiving NUCALA, tell your healthcare provider about all of your medical conditions, including if you:

  • are taking oral or inhaled corticosteroid medicines. Do not stop taking your other medicines, including your corticosteroid medicines, unless instructed by your healthcare provider because this may cause other symptoms to come back.
  • have a parasitic (helminth) infection.
  • are pregnant or plan to become pregnant. It is not known if NUCALA may harm your unborn baby.
  • are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will use NUCALA and breastfeed. You should not do both without talking with your healthcare provider first.
  • are taking prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and tiredness (fatigue). Mouth/throat pain and joint pain have been reported with CRSwNP. Diarrhea and cough have been reported with COPD.

Please see full Prescribing Information for NUCALA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at gsk.public.reportum.com or 1-888-825-5249.
Visit GSK Help Center website

Explore the GSK Help Center website to find customer service support and contact information.

Visit GSK For You website

If you have questions about how to access your GSK medication or need cost information, visit gskforyou.com or call 1-866-GSK-FOR-U (1-866-475-3678).